Impact of sofosbuvir and daclastavir on health-related quality of life in patients co-infected with hepatitis C and human immunodeficiency virus

Impact of sofosbuvir and daclastavir on health-related quality of life in patients co-infected with hepatitis C and human immunodeficiency virus

Abstract Background We conducted a real-life study of health-related quality of life (HRQoL) transformation before and 12 weeks after sofosbuvir and daclatasvir therapy in HCV/HIV co-infected patients. Factors related to the significant changes of each HRQoL domain/item were also evaluated. Methods...

Full description

Bibliographic Details
Main Authors: Evy Yunihastuti, Fhadilla Amelia, Arini Ika Hapsari, Bramantya Wicaksana, Veritea Natali, Alvina Widhani, Andri Sanityoso Sulaiman, Teguh Harjono Karjadi
Format: Article
Language:English
Published: BMC 2021-05-01
Series:Health and Quality of Life Outcomes
Subjects:
Health-related quality of life
Hepatitis C
HCV
HIV
Sofosbuvir
Daclastavir
Online Access:https://doi.org/10.1186/s12955-021-01777-x

Internet

https://doi.org/10.1186/s12955-021-01777-x

Similar Items